There is no workforce better than India’s: Rajiv Malik, Mylan – The Financial Express
0
Mylan is the world’s second-largest generic drug player in terms of revenue. However, the behemoth is yet to make inroads into the Indian market. The company entered India in 2007 with its buy of Matrix Laboratories. Since then, it has espoused the inorganic growth theory. Mylan’s India arm now constitutes nearly 50% of its global employee strength. President Rajiv Malik, who oversees Mylan’s R&D activity as well as regulatory affairs, manufacturing and quality, spoke to Pallavi Ail on why the company is cautious while negotiating Indian pharma waters. Excerpts…
Read more – The Financial Express